| States with prescription drug monitoring mandates saw a reduction in opioids prescribed to Medicaid enrollees H Wen, BR Schackman, B Aden, Y Bao Health Affairs 36 (4), 733-741, 2017 | 139 | 2017 |
| Prescription drug monitoring program mandates: impact on opioid prescribing and related hospital use H Wen, JM Hockenberry, PJ Jeng, Y Bao Health Affairs 38 (9), 1550-1556, 2019 | 96 | 2019 |
| Assessing the impact of state policies for prescription drug monitoring programs on high-risk opioid prescriptions Y Bao, K Wen, P Johnson, PJ Jeng, ZF Meisel, BR Schackman Health Affairs 37 (10), 1596-1604, 2018 | 93 | 2018 |
| Cost-effectiveness of buprenorphine–naloxone versus extended-release naltrexone to prevent opioid relapse SM Murphy, KE McCollister, JA Leff, X Yang, PJ Jeng, JD Lee, EV Nunes, ... Annals of internal medicine 170 (2), 90-98, 2019 | 57 | 2019 |
| Patient experience with outpatient encounters at public hospitals in Shanghai: examining different aspects of physician services and implications of overcrowding Y Bao, G Fan, D Zou, T Wang, D Xue PLoS One 12 (2), e0171684, 2017 | 49 | 2017 |
| Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City CN Behrends, D Paone, ML Nolan, E Tuazon, SM Murphy, SN Kapadia, ... Journal of Substance Abuse Treatment 106, 79-88, 2019 | 34 | 2019 |
| Will converting naloxone to over‐the‐counter status increase pharmacy sales? SM Murphy, JR Morgan, PJ Jeng, BR Schackman Health services research 54 (4), 764-772, 2019 | 33 | 2019 |
| State Medicaid hepatitis C treatment eligibility criteria and use of direct-acting antivirals SN Kapadia, PJ Jeng, BR Schackman, Y Bao Clinical Infectious Diseases 66 (10), 1618-1620, 2018 | 28 | 2018 |
| COVID-19 could change the way we respond to the opioid crisis—for the better Y Bao, AR Williams, BR Schackman Psychiatric Services 71 (12), 1214-1215, 2020 | 26 | 2020 |
| First opioid prescription and subsequent high-risk opioid use: a national study of privately insured and Medicare Advantage adults Y Zhang, P Johnson, PJ Jeng, MC Reid, LR Witkin, BR Schackman, ... Journal of General Internal Medicine 33, 2156-2162, 2018 | 23 | 2018 |
| Association between jail‐based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011–17 S Lim, T Cherian, M Katyal, KS Goldfeld, R McDonald, E Wiewel, M Khan, ... Addiction 118 (3), 459-467, 2023 | 19 | 2023 |
| Psychiatric case review and treatment intensification in collaborative care management for depression in primary care NA Sowa, P Jeng, AM Bauer, JM Cerimele, J Unützer, Y Bao, L Chwastiak Psychiatric Services 69 (5), 549-554, 2018 | 19 | 2018 |
| Can artificial intelligence help identify elder abuse and neglect? T Rosen, Y Zhang, Y Bao, S Clark, A Elman, K Wen, P Jeng, MS Lachs Journal of elder abuse & neglect 32 (1), 97-103, 2020 | 15 | 2020 |
| State opioid limits and volume of opioid prescriptions received by medicaid patients H Zhang, S Tallavajhala, SN Kapadia, PJ Jeng, Y Shi, H Wen, Y Bao Medical care 58 (12), 1111, 2020 | 13 | 2020 |
| Health-related quality of life and opioid use disorder pharmacotherapy: a secondary analysis of a clinical trial A Jalali, DA Ryan, PJ Jeng, KE McCollister, JA Leff, JD Lee, EV Nunes, ... Drug and alcohol dependence 215, 108221, 2020 | 12 | 2020 |
| Prescription drug monitoring program mandates and opioids dispensed following emergency department encounters for patients with sickle cell disease or cancer with bone metastasis H Zhang, AS Kilaru, ZF Meisel, Y Bao JAMA 326 (3), 274-276, 2021 | 11 | 2021 |
| Design of a Payment Decision–Support Tool for Coordinated Specialty Care for Early Psychosis Y Bao, Y Li, PJ Jeng, J Scodes, MA Papp, JL Humensky, M Wall, R Lee, ... Psychiatric Services 72 (2), 180-185, 2021 | 10 | 2021 |
| State policies for prescription drug monitoring programs and adverse opioid-related hospital events K Wen, P Johnson, PJ Jeng, BR Schackman, Y Bao Medical care 58 (7), 610, 2020 | 10 | 2020 |
| Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two … SM Murphy, PJ Jeng, SA Poole, A Jalali, FJ Vocci, MS Gordon, GE Woody, ... Addiction Science & Clinical Practice 15 (1), 1-11, 2020 | 9 | 2020 |
| Cost-effectiveness of a medical care coordination program for people with HIV in Los Angeles County MJE Flash, WH Garland, EB Martey, BR Schackman, S Oksuzyan, ... Open Forum Infectious Diseases 6 (12), ofz537, 2019 | 9 | 2019 |
Ali JalaliJoan & Sanford I. Weill Medical College of Cornell UniversityVerificeret mail på med.cornell.edu
